DPX+rPA | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

3,771 results for “DPX+rPA”

Trials

View all 2434 →

Anthrax-rPA: Safety, Tolerability, Immunogenicity

80 participants · First posted Jul 8, 2003

UMD rPA Regimen Trial in Adults

270 participants · First posted Aug 23, 2005

DPX-Survivac and Checkpoint Inhibitor in DLBCL

25 participants · First posted Nov 21, 2017

Drugs

View all 804 →

DPX-rPA

DPX-SurMAGE/CPA

DPX-rHA

Organizations

View all 142 →

DPT LABORATORIES, LTD.

United States

DPT LAKEWOOD, LLC

United States

DPT Laboratories Ltd.

United States

News

View all 391 →

BioVaxys Advances DPX Platform as Alternative to Lipid Nanoparticles for mRNA Vaccine Delivery

FDA Approves Damona Pharmaceuticals' DPX-101 for Phase I Trial in Brain Disorders

BioVaxys and Sona Nanotech Partner to Develop Novel Cancer Immunotherapy Combining DPX Platform with Gold Nanorod Technology

Page 1 of 378